- Home
- BCRX vs CMBT Comparison
BCRX vs CMBT Comparison
Compare BCRX & CMBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- CMBT
- Stock Information
- Founded
- BCRX 1986
- CMBT 1989
- Country
- BCRX United States
- CMBT Belgium
- Employees
- BCRX N/A
- CMBT N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- CMBT
- Sector
- BCRX Health Care
- CMBT
- Exchange
- BCRX Nasdaq
- CMBT NYSE
- Market Cap
- BCRX 1.7B
- CMBT 1.6B
- IPO Year
- BCRX 1994
- CMBT N/A
- Fundamental
- Price
- BCRX $7.40
- CMBT $9.07
- Analyst Decision
- BCRX Buy
- CMBT
- Analyst Count
- BCRX 6
- CMBT 0
- Target Price
- BCRX $15.67
- CMBT N/A
- AVG Volume (30 Days)
- BCRX 3.2M
- CMBT 74.5K
- Earning Date
- BCRX 05-05-2025
- CMBT 05-07-2025
- Dividend Yield
- BCRX N/A
- CMBT 62.79%
- EPS Growth
- BCRX N/A
- CMBT 4.48
- EPS
- BCRX N/A
- CMBT 4.44
- Revenue
- BCRX $450,712,000.00
- CMBT $940,246,000.00
- Revenue This Year
- BCRX $27.64
- CMBT $6.89
- Revenue Next Year
- BCRX $13.42
- CMBT $22.59
- P/E Ratio
- BCRX N/A
- CMBT $2.03
- Revenue Growth
- BCRX 36.00
- CMBT N/A
- 52 Week Low
- BCRX $4.03
- CMBT $7.65
- 52 Week High
- BCRX $9.50
- CMBT $21.26
- Technical
- Relative Strength Index (RSI)
- BCRX 50.46
- CMBT 51.48
- Support Level
- BCRX $6.02
- CMBT $8.67
- Resistance Level
- BCRX $7.41
- CMBT $9.22
- Average True Range (ATR)
- BCRX 0.44
- CMBT 0.47
- MACD
- BCRX 0.06
- CMBT 0.07
- Stochastic Oscillator
- BCRX 81.66
- CMBT 88.81
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About CMBT EURONAV
CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organises itself into two segments: tankers and floating storage and offloading activities, or FSO. The tankers segment, which generates the majority of revenue, operates crude oil tankers on international markets. The FSO segment conducts floating production, floating storage, and offloading operations for crude oil and petroleum products.